pipazethate
Sign in to saveAlso known as D-254, SO-15874, Pipazetate, SK&F-70230-A
Pipazetate () (brand names Dipect, Lenopect, Selvigon, Theratuss, Toraxan), or pipazethate (), is a 1-azaphenothiazine drug that was briefly marketed as a cough suppressant. It binds to the sigma-1 receptor with an IC50 value of 190 nM. It also has local anesthetic action, and in large doses can produce seizures.
Research
24 papers- Pipazethate--acute childhood poisoning.Clinical toxicology · 1977
- Severe Acute Pipazethate HCl Poisoning: A Case Report.Journal of paediatrics and child health · 2026
- Utilization of N-bromosuccinimide for the sensitive spectrophotometric determination of pipazethate HCl as antitussive drug in pure and dosage forms.Annales pharmaceutiques francaises · 2021
- Accidental lethal pipazethate poisoning in a child.Zeitschrift fur Rechtsmedizin. Journal of legal medicine · 1982
- Trial of pipazethate as an antitussive.Clinical pharmacology and therapeutics · 1966
via PubMed
Wikidata facts
- Mass
- 399.161663
Show 3 more facts
- defined daily dose
- 80
- chemical formula
- C₂₁H₂₅N₃O₃S
- canonical SMILES
- C1CCN(CC1)CCOCCOC(=O)N2C3=CC=CC=C3SC4=C2N=CC=C4
Sources (3)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- Synthesis
- References
Pipazetate () (brand names Dipect, Lenopect, Selvigon, Theratuss, Toraxan), or pipazethate (), is a 1-azaphenothiazine drug that was briefly marketed as a cough suppressant. It binds to the sigma-1 receptor with an IC50 value of 190 nM. It also has local anesthetic action, and in large doses can produce seizures.
As the brand name Theratuss, it was approved by the FDA in 1962, on evidence of safety only. It was withdrawn from the US market in 1972 when the manufacturer, Bristol Myers Squibb, failed to produce evidence of efficacy. Clinical studies showed that it did not decrease cough frequency at recommended dosages.
Available in 5 languages
via Wikidata sitelinks · CC0